July 9, 2021—According to ARRS’ American Journal of Roentgenology (AJR), reduced-dose CT depicts greater than 90% of lung nodules in children and young adults with cancer, identifying the presence of nodules with moderate sensitivity and high specificity.

July 9, 2021 — XIFIN announced the acquisition of Computerized Management Services (CMS), a provider of revenue cycle management (RCM) services for radiology groups and imaging centers. This acquisition builds on XIFIN’s RCM leadership and footprint across the diagnostic industry, providing healthcare organizations with specialized solutions and services that streamline and optimize the billing process, improve claims management, and provide leaders with greater business visibilit

July 9, 2021 — The FDA has granted 510(k) clearance for DeepLook, Inc.’s DL Precise, a one-click software tool to automate segmentation and measurement of suspicious objects across all medical imaging modalities, delivering critical improvements in workflow and reporting precision.

July 8, 2021 — Intelerad Medical Systems, a global leader in medical image management solutions, announced its acquisition of Heart Imaging Technologies (HeartIT), the leader in clinical workflow automation. Headquartered in the Raleigh-Durham area, HeartIT provides web-based medical image management technology and services to health systems, large hospitals and private clinics, as well as drug and device companies sponsoring multi-center clinical trials.

July 8, 2021 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 63rd Annual Meeting, which will return to an in-person conference at McCormick Place West in Chicago, October 24-27, 2021. General registration is available at www.astro.org/annualmeeting.

July 8, 2021 — Fujifilm Medical Systems U.S.A., Inc. announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Fujifilm’s new image enhancement technology - the Oxygen Saturation Endoscopic Imaging System - which was developed to improve visualization during gastrointestinal, colorectal, and advanced endoscopy and surgical procedures.

July 8, 2021 — Biogen and Eisai Co., Ltd. announced the U.S. Food and Drug Administration (FDA) has approved an updated label for Aduhelm (aducanumab-avwa) injection 100 mg/mL solution.

July 7, 2021 — Annalise.ai has launched its comprehensive chest X-ray AI solution Annalise CXR, which detects 124 clinical findings and is a decision support tool for radiologists and clinicians. The company was originally formed as a joint venture between Australian healthcare technology company Harrison.ai and one of the world’s largest radiology companies, I–MED Radiology Network. 


The rapid increase in global cancer prevalence is driving the demand for innovative and accurate oncology treatment practices.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now